https://prabadinews.com/

Email

weborders@prabadincorp.com

Call us

+1 (786)-332-3938
administrator
endo-usa,-inc.-issues-voluntary,-nationwide-recall-of-adrenalin-chloride-solution-(epinephrine-nasal-solution,-usp)-due-to-the-potential-for-administration-errors FDA
  • December 20, 2024

Endo USA, Inc. Issues Voluntary, Nationwide Recall of Adrenalin® Chloride Solution (EPINEPHrine Nasal Solution, USP) Due to the Potential for Administration Errors

Endo, Inc (OTCQX: NDOI) (“Endo”), announced today that one of its operating subsidiaries, Endo USA, Inc., is voluntarily recalling all…
orgain-issues-voluntary-allergy-alert-on-possible-undeclared-peanut-residue-in-a-single-batch-of-30g-protein-organic-plant-based-powder-–-chocolate-2.01lb FDA
  • December 19, 2024

Orgain Issues Voluntary Allergy Alert on Possible Undeclared Peanut Residue in a Single Batch of 30G Protein Organic Plant Based Powder – Chocolate 2.01lb

Orgain of Irvine, California is voluntarily recalling a single batch of its 30g Protein Organic Plant Based Powder – Chocolate…
Drug Test
  • December 19, 2024

The Emergence of a Novel Synthetic Nicotine Analog 6‐Methyl Nicotine (6‐MN) in Proclaimed Tobacco‐ and Nicotine‐Free Pouches Available in Europe

At the beginning of 2024, self-proclaimed tobacco- and nicotine-free pouches became available on the European market. Upon chemical analysis of…
Drug Test
  • December 19, 2024

Further Investigation Into an Environmental Source for Aminorex

The results provide evidence that resedine is an intermediary compound between barbarin and aminorex in horses and that resedine can…
984:-n-acetylcysteine-in-acute-liver-failure-not-caused-by-acetaminophen Healthcare
  • December 19, 2024

984: N-acetylcysteine in Acute Liver Failure Not Caused by Acetaminophen

Show notes at pharmacyjoe.com/episode984. In this episode, I’ll discuss N-acetylcysteine in non-acetaminophen-induced acute liver failure. The post 984: N-acetylcysteine in…
implantable-marker-recall:-hologic-removes-biozorb-3d-bioabsorbable-markers-due-to-risk-for-patient-complications FDA
  • December 18, 2024

Implantable Marker Recall: Hologic Removes BioZorb 3D Bioabsorbable Markers due to Risk for Patient Complications

BioZorb Markers are implantable and used to mark soft tissue for procedures. They are being recalled after reports of patient…
update:-do-not-use-biozorb-marker-implantable-radiographic-marker-devices:-fda-safety-communication FDA
  • December 18, 2024

Update: Do Not Use BioZorb Marker Implantable Radiographic Marker Devices: FDA Safety Communication

The FDA’s updated information about BioZorb Marker.
catheter-correction:-boston-scientific-updates-use-instructions-for-polarx-and-polarx-fit-cryoablation-balloon-catheters-due-to-higher-than-anticipated-number-of-reports-of-atrio-esophageal-fistula FDA
  • December 18, 2024

Catheter Correction: Boston Scientific Updates Use Instructions for POLARx and POLARx FIT Cryoablation Balloon Catheters due to Higher than Anticipated Number of Reports of Atrio-Esophageal Fistula

POLARx Cryoablation Balloon Catheters treat atrial fibrillation. After reports of atrio-esophageal fistula, the use instructions are being updated.
hologic,-inc.-recalls-biozorb-marker-due-to-complications-with-implanted-devices FDA
  • December 18, 2024

Hologic, Inc. Recalls BioZorb Marker Due to Complications with Implanted Devices

Hologic, Inc. is recalling BioZorb Marker due to complications and adverse events with implanted devices.
a-christman-present-from-astp Healthcare
  • December 17, 2024

A Christman present from ASTP

#HTI2 Part 2 just dropped. At 54 pages, Health Data, Technology, and Interoperability: Protecting Care Access is one of the…